A study suggests boosting “naturally-produced” antibodies in mothers may enhance infants’ immunity against bacterial pathogens that cause infectious gastrointestinal diseases.
New York City Mayor Bill de Blasio announced Monday parents whose children are currently enrolled in all-remote classes will now have until Nov. 15 to opt back into in-person classes. Noliwe Rooks, anexpert in cultural and racial implications for education, says it’s the responsibility of New York City officials to lead conversations with parents around safety concerns of in-person education, rather than making their anxieties a political issue.
On Monday, Gov. Andrew Cuomo ordered new restrictions on COVID-19 hot spots in New York City, including the closure of all private and public schools in the nine city ZIP codes with upticks in coronavirus transmissions. Isaac Weisfuse, a medical epidemiologist at Cornell University says the restrictions are a wise decision to stop the spread of coronavirus but is concerned the interventions may be too late.
Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia, according to a preclinical study by investigators at Weill Cornell Medicine.
Weill Cornell Medicine’s Clinical and Translational Science Center has been awarded a two-year, $1.5 million NIH grant to investigate how social and biological factors help determine COVID-19 outcomes in New York City patients.
Applications are open for the Contribution Project, a program that grants $400 each to undergraduates with ideas for how to make a difference in the world.
Teams from eLab, Cornell’s student accelerator, and Cornell Tech’s Runway Startups program will pitch their ideas to the West Coast Cornell community at Cornell Silicon Valley Presents: Student Startup Showcase March 30 at the Autodesk Gallery in San Francisco.
Abnormalities in a type of brain cell called astrocytes may play a pivotal role in causing some behavioral symptoms of autism spectrum disorders, according to a preclinical study by Weill Cornell Medicine investigators.
Cornell University experts are available to weigh in on New York City's proposed congestion pricing and its potential impacts on traffic congestion, public transit ridership, greenhouse gas emissions as well as equity implications and health benefits.
